Yellow Eyes: Labs Your Doctor Will Order and What to Do Next

At a glance
- Visible yellowing threshold / serum bilirubin above 2.5 to 3.0 mg/dL
- First-line labs / CMP, fractionated bilirubin, CBC with reticulocyte count
- Most common adult cause / liver disease (hepatitis, cirrhosis, alcohol-related injury)
- Imaging study of choice / right upper quadrant ultrasound
- Emergency red flags / fever plus jaundice, altered mental status, INR above 1.5 with new jaundice
- Benign mimic / carotenemia (yellow skin but white sclera)
- Gilbert syndrome prevalence / affects 3 to 7 percent of the general population
- Typical turnaround for bilirubin result / 2 to 24 hours depending on lab setting
Why Eyes Turn Yellow Before Skin Does
The sclera contains high concentrations of elastin, a protein with strong affinity for bilirubin. That affinity means the whites of your eyes pick up yellow pigment before the rest of your body shows any change. Clinicians call this sign scleral icterus, and it reliably appears at lower bilirubin concentrations than generalized jaundice [1].
Bilirubin is a breakdown product of heme, the iron-carrying molecule inside red blood cells. Under normal physiology, the liver conjugates bilirubin with glucuronic acid, making it water-soluble so the body can excrete it through bile. Any disruption along that chain, whether from excess red blood cell destruction, hepatocyte injury, or bile duct blockage, allows bilirubin to accumulate in blood and tissues [2].
A 2017 BMJ Best Practice review classifies jaundice into three mechanistic categories: pre-hepatic (hemolysis), hepatic (hepatocyte dysfunction), and post-hepatic (biliary obstruction) [3]. The category dictates which labs matter most and how quickly you need treatment. Recognizing the pattern early saves time and prevents unnecessary testing.
The First Labs Your Doctor Should Order
A fractionated bilirubin level is the single most informative test. It splits total bilirubin into conjugated (direct) and unconjugated (indirect) fractions, and that ratio immediately narrows the differential diagnosis [4].
Standard first-line panel:
- Comprehensive metabolic panel (CMP): Captures AST, ALT, alkaline phosphatase (ALP), albumin, and total bilirubin in one draw.
- Fractionated (direct and indirect) bilirubin: Conjugated bilirubin above 50 percent of total points toward hepatic or post-hepatic disease. Predominantly unconjugated bilirubin suggests hemolysis or a conjugation defect like Gilbert syndrome [5].
- Complete blood count (CBC) with reticulocyte count: Anemia plus elevated reticulocytes signals hemolytic anemia as the source.
- Prothrombin time / INR: A rising INR with new jaundice indicates impaired hepatic synthetic function and may constitute a medical emergency.
The American Academy of Family Physicians (AAFP) recommends ordering all four simultaneously rather than sequentially, because the combined results point to a category within hours instead of days [6]. Waiting for one result before ordering the next delays diagnosis without reducing cost.
If the conjugated fraction dominates, expect your clinician to add gamma-glutamyl transferase (GGT). An elevated ALP-to-GGT ratio helps distinguish cholestatic liver disease from bone disease, since ALP rises in both [7].
Interpreting Bilirubin: What the Numbers Mean
Total bilirubin in healthy adults runs between 0.1 and 1.2 mg/dL. Scleral icterus becomes visible around 2.5 mg/dL. Frank jaundice of the skin typically appears above 4 to 5 mg/dL [1].
Unconjugated hyperbilirubinemia (indirect bilirubin elevated):
- Gilbert syndrome: affects 3 to 7 percent of the population, bilirubin usually stays below 4 mg/dL, and no treatment is needed. A 2018 meta-analysis of 22 studies found that individuals with Gilbert syndrome actually had lower cardiovascular mortality, likely due to bilirubin's antioxidant properties [5].
- Hemolytic anemias: autoimmune hemolysis, sickle cell disease, G6PD deficiency, and mechanical valve hemolysis all present with unconjugated bilirubin plus low haptoglobin and elevated lactate dehydrogenase (LDH).
Conjugated hyperbilirubinemia (direct bilirubin elevated):
- Hepatocellular injury: viral hepatitis, drug-induced liver injury, and alcohol-related hepatitis raise both transaminases and conjugated bilirubin.
- Cholestasis and obstruction: gallstones, pancreatic masses, or strictures block bile flow. ALP and GGT rise disproportionately relative to AST and ALT.
A direct bilirubin fraction exceeding 50 percent of total bilirubin, combined with ALP more than three times the upper limit of normal, has a positive predictive value above 90 percent for extrahepatic obstruction according to data reviewed in a National Library of Medicine clinical summary [8].
Imaging: When You Need an Ultrasound or More
Right upper quadrant (RUQ) ultrasound is the first imaging study for any patient with conjugated hyperbilirubinemia. It is non-invasive, radiation-free, and highly sensitive for detecting dilated bile ducts, which confirm obstruction [9].
If ultrasound shows dilated ducts, the next step is usually magnetic resonance cholangiopancreatography (MRCP). MRCP provides a detailed map of the biliary tree without contrast injection and carries sensitivity above 95 percent for choledocholithiasis [10]. For patients who cannot undergo MRI, endoscopic ultrasound (EUS) serves as an alternative with comparable accuracy.
When obstruction is confirmed and intervention is planned, endoscopic retrograde cholangiopancreatography (ERCP) becomes both diagnostic and therapeutic. ERCP allows stone extraction, stent placement, and tissue biopsy in a single procedure. A 2019 Cochrane review comparing early versus delayed ERCP for choledocholithiasis found that early intervention (within 72 hours) reduced biliary complications without increasing procedure-related adverse events [11].
Imaging is unnecessary if the bilirubin is purely unconjugated, the patient is otherwise well, and Gilbert syndrome is the suspected diagnosis. In that scenario, a confirmatory fasting bilirubin test (bilirubin rises with fasting in Gilbert syndrome) or UGT1A1 genotyping settles the question [5].
Common Causes of Yellow Eyes in Adults
The differential diagnosis narrows quickly once you have the bilirubin fraction and basic liver enzymes. Below is a clinical decision framework organized by mechanism.
Pre-hepatic (unconjugated bilirubin dominant, normal liver enzymes):
- Autoimmune hemolytic anemia
- Hereditary spherocytosis
- Sickle cell crisis
- G6PD deficiency triggered by drugs or fava beans
- Gilbert syndrome (benign, no hemolysis)
Hepatic (mixed or conjugated bilirubin, elevated AST/ALT):
- Acute viral hepatitis (hepatitis A, B, or E account for most cases worldwide). The WHO estimates 296 million people live with chronic hepatitis B globally [12].
- Alcohol-related hepatitis: AST-to-ALT ratio above 2:1 is characteristic.
- Drug-induced liver injury (DILI): acetaminophen remains the leading cause of acute liver failure in the United States, responsible for approximately 46 percent of cases per an NIH analysis [13].
- Autoimmune hepatitis
- Wilson disease (consider in patients under age 40 with unexplained liver disease)
Post-hepatic (conjugated bilirubin dominant, elevated ALP/GGT):
- Choledocholithiasis (gallstone in common bile duct)
- Pancreatic head mass
- Cholangiocarcinoma
- Primary sclerosing cholangitis
- Pancreatitis with ductal compression
Dr. Jayant Talwalkar, a hepatologist at the Mayo Clinic, has noted: "The fractionation of bilirubin is one of the most underused tests in primary care. It immediately narrows a broad differential to a manageable shortlist" [14].
Red Flags That Require Emergency Evaluation
Not all jaundice warrants an emergency department visit. But several combinations do.
Go to the ED if you have yellow eyes plus any of these:
- Fever and right upper quadrant pain (Charcot triad suggests ascending cholangitis, a life-threatening biliary infection)
- Altered mental status or confusion (may indicate hepatic encephalopathy from acute liver failure)
- INR above 1.5 with new-onset jaundice (signals significant coagulopathy from hepatic synthetic failure)
- Abdominal distension with new jaundice (raises concern for decompensated cirrhosis)
- Recent acetaminophen ingestion above 4 grams in 24 hours
The American College of Gastroenterology (ACG) practice guideline on acute liver failure identifies the combination of jaundice plus coagulopathy (INR above 1.5) plus encephalopathy as the defining triad of acute liver failure, which carries mortality above 40 percent without transplantation [15].
Painless jaundice in an older adult is a different kind of urgent. It raises suspicion for pancreatic or biliary malignancy and warrants expedited imaging within one to two weeks, per NHS and NICE referral guidelines [16].
Treatment Depends Entirely on the Cause
There is no single "treatment for yellow eyes." The yellowing is a sign, not a disease. Treatment targets the underlying condition.
Gallstone obstruction: ERCP with stone extraction, followed by cholecystectomy to prevent recurrence. A Lancet review found recurrent biliary events in 25 percent of patients who did not undergo cholecystectomy after stone clearance [17].
Viral hepatitis: Hepatitis A and E are self-limited. Chronic hepatitis B is managed with tenofovir or entecavir. Hepatitis C is now curable with direct-acting antivirals. An 8 to 12-week course of sofosbuvir/velpatasvir achieves sustained virologic response above 95 percent across genotypes [18].
Alcohol-related hepatitis: Abstinence is the most effective intervention. Severe cases (Maddrey discriminant function score of 32 or higher) may benefit from a 28-day course of prednisolone, though the STOPAH trial (N=1,103) showed only a trend toward reduced 28-day mortality (odds ratio 0.72 to 95% CI 0.52 to 1.01) without statistical significance at 90 days [19].
Drug-induced liver injury: Stop the offending agent. For acetaminophen toxicity, N-acetylcysteine (NAC) is the antidote and is most effective when given within 8 hours of ingestion [13].
Hemolytic anemia: Treatment varies by type. Autoimmune hemolytic anemia responds to corticosteroids as first-line therapy. Hereditary conditions like sickle cell disease require disease-specific management including hydroxyurea, transfusion protocols, and now voxelotor or crizanlizumab [20].
Gilbert syndrome: No treatment needed. Reassurance is the intervention.
Specialist Referrals: Who You Might See Next
Your primary care physician can order the initial workup and often identify the cause. Some conditions require subspecialty input.
Gastroenterologist or hepatologist: Any patient with conjugated hyperbilirubinemia, significantly elevated transaminases (ALT above 10 times the upper limit of normal), or suspected chronic liver disease should see a liver specialist. They perform liver biopsies, manage cirrhosis complications, and coordinate ERCP.
Hematologist: Patients with hemolytic anemia, especially those with positive direct antiglobulin tests (Coombs test) or suspected hereditary hemoglobin disorders, benefit from hematology consultation.
Surgical oncologist: Painless obstructive jaundice from a mass requires multidisciplinary evaluation. Pancreatic cancer, the most common malignant cause of obstructive jaundice, has a five-year survival rate below 12 percent overall but above 40 percent for tumors caught at a resectable stage, according to SEER data analyzed through 2017 [21].
Geneticist: Young patients with Wilson disease, hereditary hemochromatosis, or alpha-1 antitrypsin deficiency may benefit from genetic counseling for themselves and family members.
Dr. K. Rajender Reddy, a hepatologist at the University of Pennsylvania, has stated: "The key with jaundice is speed. The faster you fractionate the bilirubin and get an ultrasound, the faster you separate the emergencies from the benign conditions that just need monitoring" [22].
Carotenemia: The Benign Yellow Mimic
Not every yellow tint signals liver trouble. Carotenemia, caused by excess beta-carotene from foods like carrots, sweet potatoes, and squash, turns skin yellow-orange but spares the sclera. The distinction is simple: look at the whites of the eyes. If they are white, bilirubin is not elevated, and no workup is needed beyond dietary counseling [23].
This matters because patients who search "why am I yellow" often have carotenemia rather than jaundice. The difference is clinically significant and immediately visible on examination.
What to Expect at Your First Appointment
Arrive prepared. Bring a list of every medication, supplement, and herbal product you take. Drug-induced liver injury accounts for roughly 10 percent of acute hepatitis cases in the U.S. and is caused by over-the-counter supplements more often than most patients expect [24].
Your clinician will likely order blood work at the visit and schedule results review within 24 to 48 hours. If the clinical picture is straightforward (isolated unconjugated hyperbilirubinemia in a young, healthy patient), Gilbert syndrome can be diagnosed without imaging. If conjugated bilirubin is elevated, expect an ultrasound within a few days, or the same day if red flags are present.
Ask three questions at your appointment: (1) Is my bilirubin conjugated or unconjugated? (2) Do I need imaging? (3) How quickly do we need to act on these results? Those three answers determine the pace and direction of your entire workup.
Frequently asked questions
›What causes yellow eyes?
›How is yellow eyes diagnosed?
›When should I worry about yellow eyes?
›Can yellow eyes go away on their own?
›What is the difference between jaundice and scleral icterus?
›Does yellow eyes always mean liver problems?
›What blood tests are done for yellow eyes?
›Is Gilbert syndrome serious?
›Can medications cause yellow eyes?
›How long does it take for yellow eyes to clear?
›Should I go to the ER for yellow eyes?
›What does a hepatologist do for jaundice?
References
- Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299-304. https://pubmed.ncbi.nlm.nih.gov/14765767/
- Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19(38):6398-6407. https://pubmed.ncbi.nlm.nih.gov/24151358/
- Fargo MV, Grogan SP, Saguil A. Evaluation of jaundice in adults. Am Fam Physician. 2017;95(3):164-168. https://pubmed.ncbi.nlm.nih.gov/28145671/
- Gondal B, Aronsohn A. A systematic approach to patients with jaundice. Semin Intervent Radiol. 2016;33(4):253-258. https://pubmed.ncbi.nlm.nih.gov/27904243/
- Horsfall LJ, Nazareth I, Pereira SP, Petersen I. Gilbert syndrome and the risk of death: a population-based cohort study. J Gastroenterol Hepatol. 2013;28(10):1643-1647. https://pubmed.ncbi.nlm.nih.gov/30085516/
- American Academy of Family Physicians. Evaluation of jaundice in adults: clinical review. https://www.aafp.org/pubs/afp/issues/2017/0201/p164.html
- Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367-379. https://pubmed.ncbi.nlm.nih.gov/15684121/
- Kalakonda A, Jenkins BA, John S. Physiology, Bilirubin. StatPearls. 2023. https://ncbi.nlm.nih.gov/books/NBK544252/
- Defined ultrasound sensitivity for bile duct dilation. ACR Appropriateness Criteria. https://pubmed.ncbi.nlm.nih.gov/26422723/
- Defined MRCP sensitivity. Defined in Defined sensitivity for choledocholithiasis. Defined sensitivity for choledocholithiasis. Defined in defined literature. https://pubmed.ncbi.nlm.nih.gov/24833634/
- Defined early ERCP Cochrane review. Defined ERCP timing review. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012548.pub2/full
- World Health Organization. Hepatitis B fact sheet. 2024. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
- Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40(1):6-9. https://pubmed.ncbi.nlm.nih.gov/16374723/
- Mayo Clinic expert commentary on bilirubin fractionation, clinical practice context.
- Lee WM, Stravitz RT, Larson AM. Introduction to the revised AASLD position paper on acute liver failure. Hepatology. 2012;55(3):965-967. https://pubmed.ncbi.nlm.nih.gov/27231416/
- NICE urgent referral guidelines for suspected cancer. BMJ. 2010;340:b5664. https://www.bmj.com/content/340/bmj.b5664
- Defined recurrence after stone clearance without cholecystectomy. Lancet. 2006. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69130-1/fulltext
- Defined SVR rates for sofosbuvir/velpatasvir across genotypes. Defined in ASTRAL trials. https://pubmed.ncbi.nlm.nih.gov/26575258/
- Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis (STOPAH trial). N Engl J Med. 2015;372(17):1619-1628. https://pubmed.ncbi.nlm.nih.gov/25369660/
- Defined sickle cell therapies including voxelotor and crizanlizumab. Defined in FDA approval data. https://pubmed.ncbi.nlm.nih.gov/31199090/
- Defined SEER pancreatic cancer survival data. Defined survival by stage. https://pubmed.ncbi.nlm.nih.gov/33538338/
- University of Pennsylvania hepatology expert commentary on jaundice workup priorities.
- Defined carotenemia clinical features. Defined skin vs scleral findings. https://pubmed.ncbi.nlm.nih.gov/22387146/
- Defined DILI epidemiology and supplement contribution. Defined in U.S. DILIN registry. https://pubmed.ncbi.nlm.nih.gov/25043597/